Effects of Risedronate and alendronate on colonic inflammation and bone loss in a mouse model of acute colitis

Effects of Risedronate and alendronate on colonic inflammation and bone loss in a mouse model of acute colitis

Bibliographic Details
Main Authors:	Brounais-Le Royer, B, Pierroz, D, Ebetino, H, Russell, G, Ferrari, S
Format:	Conference item
Published:	2012

Similar Items

Alendronate and ibandronate affect osteoclast formation and size differently from risedronate and zoledronate
by: Mabilleau, G, et al.
Published: (2011)

Effects of risedronate, alendronate, and minodronate alone or in combination with eldecalcitol on bone mineral density, quality, and strength in ovariectomized rats
by: Tetsuo Yano, et al.
Published: (2021-06-01)

Effect of risedronate on bone loss at discontinuation of denosumab
by: Michel Laroche, et al.
Published: (2020-12-01)

Studies to elucidate the anti-tumor mechanism of action of risedronate in human myeloma cells; Use of an analogue of risedronate reveals the effects of differential inhibition of prenylation
by: Roelofs, A, et al.
Published: (2005)

Risedronate does not reduce mechanical loading-related increases in cortical and trabecular bone mass in mice.
by: Sugiyama, T, et al.
Published: (2011)

A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis
by: M Stevenson, et al.
Published: (2005-06-01)

Adherence to alendronic or risedronic acid treatment, combined or not to calcium and vitamin D, and related determinants in Italian patients with osteoporosis
by: Calabria S, et al.
Published: (2016-04-01)

NE10790, a phosphonocarboxylate analogue of risedronate, induces human myeloma cell apoptosis in vitro
by: Roelofs, A, et al.
Published: (2004)

Alendronate in patients with calcium nephrolithiasis and loss of bone mass
by: Arrabal-Polo Miguel, et al.
Published: (2012-08-01)

Fluorescently labeled risedronate and related analogues: "magic linker" synthesis.
by: Kashemirov, B, et al.
Published: (2008)

Risedronate-loaded aerogel scaffolds for bone regeneration
by: Nahla El-Wakil, et al.
Published: (2023-12-01)

Crystal structures and molecular interactions of risedronate and zoledronate with human farnesyl diphosphate synthase
by: Kavanagh, K, et al.
Published: (2006)

Bone-targeted methotrexate–alendronate conjugate inhibits osteoclastogenesis in vitro and prevents bone loss and inflammation of collagen-induced arthritis in vivo
by: Zi’ang Xie, et al.
Published: (2018-01-01)

Synthesis and biological evaluation of alpha-halogenated bisphosphonate and phosphonocarboxylate analogues of risedronate.
by: Marma, MS, et al.
Published: (2007)

Protective effect of low-dose risedronate against osteocyte apoptosis and bone loss in ovariectomized rats.
by: Tingjun Ye, et al.
Published: (2017-01-01)

Fluorescently labeled risedronate and related analogs: Design and evaluation as imaging probes
by: Coxon, F, et al.
Published: (2008)

Fluorescently labeled risedronate and related analocs: Design and evaluation as imaging probes
by: Coxon, F, et al.
Published: (2008)

Cost–effectiveness of weekly gastro-resistant risedronate 35 mg, compared with weekly alendronate 70 mg tablets, in the treatment of postmenopausal osteoporosis in Spain
by: Enrique Casado, et al.
Published: (2023-09-01)

The Effects of Once-Weekly Alendronate 70 mg, Risedronate 35 mg and Raloxifene 60 mg Daily in the Treatment of Postmenopausal Osteoporosis in Turkish Population
by: Mesut Öktem, et al.
Published: (2007-04-01)

Selective inhibition of Rab prenylation by a phosphonocarboxylate analogue of risedronate induces apoptosis, but not S-phase arrest, in human myeloma cells.
by: Roelofs, A, et al.
Published: (2006)

Alendronate as an Effective Treatment for Bone Loss and Vascular Calcification in Kidney Transplant Recipients
by: Masanori Okamoto, et al.
Published: (2014-01-01)

First Indian prospective randomized comparative study evaluating adherence and compliance of postmenopausal osteoporotic patients for daily alendronate, weekly risedronate and monthly ibandronate regimens of bisphosphonates
by: Vishal R Tandon, et al.
Published: (2014-01-01)

RISEDRONATE REDUCES MICRO-STRUCTURAL DETERIORATION OF CORTICAL BONE ACCOMPANYING MENOPAUSE
by: Seeman, E, et al.
Published: (2010)

Histomorphometric Effects of 2% Risedronate Gel on Calvarial Bone Defects in Rabbits
by: Shabnam Aghayan, et al.
Published: (2021-03-01)

Improvement of Bone Physiology and Life Quality Due to Association of Risedronate and Anastrozole
by: Vincenzo Monda, et al.
Published: (2017-09-01)

Osteolytic Bone Loss and Skeletal Deformities in a Mouse Model for Early-Onset Paget’s Disease of Bone with <i>PFN1</i> Mutation Are Treatable by Alendronate
by: Zhu Ling, et al.
Published: (2023-10-01)

Risedronate, and its phosphonocarboxylate analogue NE10790, both induce apoptosis, but have differential effects on the cell cycle and protein prenylation in human myeloma cells.
by: Roelofs, A, et al.
Published: (2004)

Substitutions in the R1 hydroxyl and C1 phosphate positions significantly affect binding of risedronate during hydroxyapatite ceramic chromatography
by: Xia, Z, et al.
Published: (2006)

Substitution of the R1 hydroxyl and C1 phosphate of risedronate produces differences in elution profiles on hydroxyapatite ceramic chromatographic columns
by: Xia, Z, et al.
Published: (2006)

Effects of Teriparatide and Alendronate on Functional Recovery from Spinal Cord Injury and Postinjury Bone Loss
by: Shuai Wang, et al.
Published: (2025-02-01)

The Comparison of the Effect of Risedronate and Strontium Ranelate on Bone Mineral Density in Postmenopausal Women
by: Figen Yılmaz, et al.
Published: (2012-08-01)

Risedronate to Prevent Bone Loss After Sleeve Gastrectomy: Study Design and Feasibility Report of a Pilot Randomized Controlled Trial
by: Ashlyn A Swafford, et al.
Published: (2020-10-01)

The Impact of Alendronate on Bone Mineral Density of Osteoporotic Patients
by: Hamidreza Aghaei-Meybodi, et al.
Published: (2013-12-01)

Alendronate Prevents Early Periprosthetic Bone Loss in Cementless Total Hip Arthroplasty Better Than Simvastatin
by: Dragos Apostu, et al.
Published: (2022-08-01)

Once-monthly risedronate for postmenopausal osteoporosis
by: Kristina Casadei, et al.
Published: (2009-02-01)

The Effect of Alendronate Treatment on Bone Density and Bone Markers in Postmenopausal Osteoporosis
by: S. Akı, et al.
Published: (2002-03-01)

Risedronate in adults with osteogenesis imperfecta type I: increased bone mineral density and decreased bone turnover, but high fracture rate persists.
by: Bradbury, L, et al.
Published: (2012)

Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate
by: Watts, N, et al.
Published: (2004)

The effect of black cohosh extract and risedronate coadministration on bone health in an ovariectomized rat model
by: Amy L. Inselman, et al.
Published: (2024-04-01)

S100A4 promotes colon inflammation and colitis-associated colon tumorigenesis
by: Jinhua Zhang, et al.
Published: (2018-08-01)